Broken String Biosciences is a genomics company with the goal of advancing therapeutic discovery and development by assessing the stability of the genome.
To unlock new medicines, knowledge of how they interrupt our genetic code is essential.
These breaks in our DNA can have important positive and negative consequences to our health.
Precision mapping of genomic breaks, provides insights that will enable the development of novel therapies.
We are developing a platform of sequencing tools to enable the safe and sustainable development of the next generation of innovative medicines, including cell and gene therapies.
Founder team
Dr Felix Dobbs
CEO
Prof Simon Reed
CSO
Simon Kerr
Chair & COO
Dr Patrick van Eijk
Senior Scientist